Hartford Hospital Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01429259
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Center for Anti-Infective Research and Development, Hartford Hospital | Hartford Hospital - Olin Neuropsychiatry Research Center | Hartford Hospital - Olin Neuropsychiatry Research Center; Yale University | Joseph Kuti | Joseph L. Kuti, PharmD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

Cystic Fibrosis (Phase 4)

Fibrosis (Phase 4)

Infections (Phase 1)

Pneumonia (Phase 4)

Pseudomonas Infections (Phase 4)

Pulmonary Fibrosis (Phase 4)

Wound Infection (Phase 1)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10